850706C

16:1 PE

1,2-dipalmitoleoyl-sn-glycero-3-phosphoethanolamine, chloroform

• Synonym(e): 1,2-di-(9Z-hexadecenoyl)-sn-glycero-3-phosphoethanolamine; PE(16:1(9Z)/16:1(9Z))
• Empirische Formel (Hill-System): C₃₇H₇₀NO₈P
• CAS-Nummer: 61599-23-3
• Molekulargewicht: 687.93
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 2.5 mL (850706C-25mg); pkg of 2 × 4 mL (850706C-200mg)
• Hersteller/Markenname: Avanti Polar Lipids 850706C
• Konzentration: 10 mg/mL (850706C-25mg); 25 mg/mL (850706C-200mg)
• Lipid-Typ: phospholipids; cardiolipins
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCCCC)=O)COC(CCCCCCC/C=C\CCCCCC)=O

Beschreibung

Allgemeine Beschreibung

Phosphatidylethanolamine (PE), a phospholipid is found abundantly in mammalian cells.

Anwendung

1,2-dipalmitoleoyl-sn-glycero-3-phosphoethanolamine (16:1 PE) may be used in the preparation of vesicles and in micelle preparation for cell experiments.

Biochem./physiol. Wirkung

Phosphatidylethanolamine (PE) serves as a lipid chaperone that supports in the folding of membrane proteins.

Verpackung

5 mL Clear Glass Sealed Ampule (850706C-200mg)

5 mL Clear Glass Sealed Ampule (850706C-25mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302 - H315 - H319 - H331 - H336 - H351 - H361d - H372 - H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• Lagerklassenschlüssel: 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): does not flash
• Flammpunkt (°C): does not flash